Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
885,665
-
Share change
-
+10,745
-
Total reported value
-
$5,405,454
-
Price per share
-
$6.10
-
Number of holders
-
25
-
Value change
-
+$44,647
-
Number of buys
-
7
-
Number of sells
-
6
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2022
As of 31 Dec 2022,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
885,665 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Bleichroeder LP, MORGAN STANLEY, SHUFRO ROSE & CO LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, OVERBROOK MANAGEMENT CORP, Strategic Financial Services, Inc,, and PERRITT CAPITAL MANAGEMENT INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.